Natera Inc

2026-09-18 22:31; UTC

Natera Inc declined in after-market trading, moving lower since Friday's close, despite previously trading above its 20-day moving average.

2026-09-17 23:06; UTC

Natera Inc's shares traded flat in after-market hours, remaining 10.18% above the 20-day moving average amid positive economic indicators.

2026-09-16 19:07; UTC

Natera Inc shares fell modestly lower, reaching a notable low today, though remaining above their 20-day moving average.

2026-09-15 23:01; UTC

Natera Inc shares are higher in after-market hours following Tuesday's close, continuing a trend of four consecutive sessions that also closed higher.

2026-09-14 19:26; UTC

Natera Inc is gaining momentum as it breaks above September's value area. UBS raised its price target while maintaining a "buy" rating.

2026-09-11 22:51; UTC

Natera Inc shares are lower in after-market hours, with no specific news identified to explain the movement. Broader market sentiment may be influencing trading.

2026-09-09 20:07; UTC

UBS has raised its price target on Natera Inc. to $435, maintaining a Buy rating and contributing to a rise in shares during Wednesday's session.

2026-09-08 23:06; UTC

Natera Inc. shares are higher in after-market trading, maintaining upward momentum since Tuesday's close despite an earlier pullback. The stock is above its 20-day moving average.

2026-09-03 19:36; UTC

Baird raised Natera's price target to $376 from $348, maintaining an Outperform rating. Shares are higher since Wednesday's close amid easing interest rate concerns.

2026-09-02 23:26; UTC

Natera Inc. shares are higher in after-market trading, continuing a strong performance over the past month, well above the 20-day moving average.

2026-09-01 19:36; UTC

Natera's Signatera test shows 100% predictive value for lymphoma treatment responses, boosting shares higher during Tuesday's session.

2026-08-31 23:01; UTC

Natera Inc shares are higher in after-market trading, stabilizing near earlier highs amid broader economic concerns over potential interest rate hikes.

2026-08-28 20:02; UTC

Natera Inc partners with Susan G. Komen to enhance breast cancer education. Shares are lower amid high trading volume and broader market pressures.

2026-08-27 20:07; UTC

Natera partners with Angiex to use Signatera in a Phase I trial for AGX101, aimed at enhancing cancer treatment response evaluation. Shares are roughly flat.

2026-08-26 19:26; UTC

Natera Inc's shares are higher today, reflecting a general market uptrend. The stock remains above its 20-day moving average and near a one-month high.

2026-08-24 19:46; UTC

Natera Inc shares are lower today, pulling back from earlier session highs. Rising oil prices and geopolitical tensions impact overall market sentiment.

2026-08-21 20:06; UTC

Natera Inc shares are higher today, rebounding from an early dip amid positive momentum in the biotechnology sector and overall market performance.

2026-08-20 23:16; UTC

Natera Inc. shares are slightly higher in after-market hours, remaining near the upper end of their one-month range amid broader market pressure from rising yields.

2026-08-19 20:02; UTC

Natera Inc shares are higher today amid a broader market rally, with notably increased trading volume indicating heightened investor interest.

2026-08-18 23:36; UTC

Natera Inc shares are lower in after-market hours, with no specific news identified. Broader market sentiment is impacted by declines in the Nikkei 225 Index.

2026-08-17 19:36; UTC

Natera Inc reports second-quarter revenue of $752.8 million, exceeding expectations. Shares are higher as the company cites strong test volume growth and regulatory approvals.

2026-08-13 19:26; UTC

Natera Inc is trading lower despite announcing a collaboration on a Phase 1 clinical trial and exceeding second-quarter expectations by $100 million.

2026-08-12 20:06; UTC

Natera Inc shares are rising after analyst upgrades and support for a Phase 1 trial in Germany using its Latitude assay to monitor tumor DNA.

2026-08-11 20:02; UTC

Natera Inc reported strong Q2 revenue of $752.8 million but shares are lower amid concerns over significant insider selling.

2026-08-10 20:02; UTC

Natera Inc shares are lower amid negative sentiment from insider selling, despite recent analyst upgrades and price target increases from Morgan Stanley and Barclays.

2026-08-07 20:03; UTC

Natera Inc. shares rise sharply after analyst upgrades and strong earnings. RBC Capital raised its price target to $350, citing robust revenue growth.

2026-08-06 23:02; UTC

Natera Inc reported second-quarter revenue of $752.8 million, exceeding expectations. The stock is trading higher after the market closed, following strong earnings results.

2026-08-05 23:01; UTC

Natera Inc announced an application for the Signatera test in Japan. Shares are trading lower in after-market hours following the announcement.

2026-08-04 19:04; UTC

Natera Inc shares are rising amid a broader market rally and high trading volume, despite challenges from declining U.S. factory orders and falling oil prices.

2026-08-03 19:23; UTC

Natera Inc. shares are higher today, reflecting broader market gains amid strong manufacturing data and significant increases in major technology stocks.